Home / Healthcare / Medical Device / Recombinant Vaccines Market

Recombinant Vaccines Market Size, Share & COVID-19 Impact Analysis, By Type (Subunit and Live Attenuated), By Route of Administration (Parenteral and Oral), By Disease Indication (Human Papillomavirus (HPV), Hepatitis B, Rotavirus, Herpes Zoster, Meningococcal B, and Others), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2020-2027

Report Format: PDF | Latest Update: Feb, 2025 | Published Date: Aug, 2020 | Report ID: FBI101935 | Status : Published
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. New Product Launch
    2. Pipeline Analysis
    3. Technological Advancements in the Recombinant Vaccines Market
    4. Prevalence of Key Diseases- For Key Countries, 2019
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  5. Global Recombinant Vaccines Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Subunit
      2. Live Attenuated
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    4. Market Analysis, Insights and Forecast – By Disease Indication
      1. Human Papillomavirus
      2. Hepatitis B
      3. Rotavirus
      4. Herpes Zoster
      5. Meningococcal B
      6. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Recombinant Vaccines Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Type
      1. Subunit
      2. Live Attenuated
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    4. Market Analysis, Insights and Forecast – By Disease Indication
      1. Human Papillomavirus
      2. Hepatitis B
      3. Rotavirus
      4. Herpes Zoster
      5. Meningococcal B
      6. Others
    5. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
  7. Europe Recombinant Vaccines Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Type
      1. Subunit
      2. Live Attenuated
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    4. Market Analysis, Insights and Forecast – By Disease Indication
      1. Human Papillomavirus
      2. Hepatitis B
      3. Rotavirus
      4. Herpes Zoster
      5. Meningococcal B
      6. Others
    5. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Recombinant Vaccines Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Type
      1. Subunit
      2. Live Attenuated
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    4. Market Analysis, Insights and Forecast – By Disease Indication
      1. Human Papillomavirus
      2. Hepatitis B
      3. Rotavirus
      4. Herpes Zoster
      5. Meningococcal B
      6. Others
    5. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Recombinant Vaccines Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Type
      1. Subunit
      2. Live Attenuated
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    4. Market Analysis, Insights and Forecast – By Disease Indication
      1. Human Papillomavirus
      2. Hepatitis B
      3. Rotavirus
      4. Herpes Zoster
      5. Meningococcal B
      6. Others
    5. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Recombinant Vaccines Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Type
      1. Subunit
      2. Live Attenuated
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    4. Market Analysis, Insights and Forecast – By Disease Indication
      1. Human Papillomavirus
      2. Hepatitis B
      3. Rotavirus
      4. Herpes Zoster
      5. Meningococcal B
      6. Others
    5. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & Services, SWOT analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. GlaxoSmithKline plc.
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Merck & Co., Inc
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Pfizer Inc
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Dynavax Technologies
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Sanofi
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Serum Institute of India Pvt. Ltd
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Novartis AG
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Other Prominent Players
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
  12. Strategic Recommendations

List of Tables

Table 1:  Global Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Type, 2016-2027

Table 2:  Global Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 3:  Global Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 4:  Global Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 5:  Global Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Region, 2016-2027

Table 6:  North America Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Type, 2016-2027

Table 7:  North America Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 8:  North America Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 9:  North America Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 10:  North America Recombinant Vaccines Market Revenue (US$ Bn) Forecast, By Country, 2016-2027

Table 11:  Europe Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Type, 2016-2027

Table 12:  Europe Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 13:  Europe Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 14:  Europe Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 15:  Europe Recombinant Vaccines Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 16:  Asia Pacific Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Type, 2016-2027

Table 17:  Asia Pacific Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 18:  Asia Pacific Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 19:  Asia Pacific Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 20:  Asia Pacific Recombinant Vaccines Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 21:  Latin America Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Type, 2016-2027

Table 22:  Latin America Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 23:  Latin America Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 24:  Latin America Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 25:  Latin America Recombinant Vaccines Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 26:  Middle East & Africa Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Type, 2016-2027

Table 27:  Middle East & Africa Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 28:  Middle East & Africa Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 29:  Middle East & Africa Recombinant Vaccines Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 30:  Middle East & Africa Recombinant Vaccines Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

List of Figures

Figure 1:  Global Recombinant Vaccines Market Revenue Breakdown (US$ Bn, %) by Region, 2019 & 2027

Figure 2:  Global Recombinant Vaccines Market Value Share (%), by Type, 2019 & 2027

Figure 3:  Global Recombinant Vaccines Market Forecast (US$ Bn), by Subunit, 2016-2027

Figure 4:  Global Recombinant Vaccines Market Forecast (US$ Bn), by Live Attenuated, 2016-2027

Figure 5:  Global Recombinant Vaccines Market Value Share (%), by Route of Administration, 2019 & 2027

Figure 6:  Global Recombinant Vaccines Market Forecast (US$ Bn), by Parenteral, 2016-2027

Figure 7:  Global Recombinant Vaccines Market Forecast (US$ Bn), by Oral, 2016-2027

Figure 8:  Global Recombinant Vaccines Market Value Share (%), by Disease Indication, 2019 & 2027

Figure 9:  Global Recombinant Vaccines Market Forecast (US$ Bn), by Human Papillomavirus, 2016-2027

Figure 10:  Global Recombinant Vaccines Market Forecast (US$ Bn), by Hepatitis B, 2016-2027

Figure 11:  Global Recombinant Vaccines Market Forecast (US$ Bn), by Rotavirus, 2016-2027

Figure 12:  Global Recombinant Vaccines Market Forecast (US$ Bn), by Herpes Zoster, 2016-2027

Figure 13:  Global Recombinant Vaccines Market Forecast (US$ Bn), by Meningococcal B, 2016-2027

Figure 14:  Global Recombinant Vaccines Market Forecast (US$ Bn), by Others, 2016-2027

Figure 15:  Global Recombinant Vaccines Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 16:  Global Recombinant Vaccines Market Forecast (US$ Bn), by Hospitals & Retail Pharmacies, 2016-2027

Figure 17:  Global Recombinant Vaccines Market Forecast (US$ Bn), by Government Suppliers, 2016-2027

Figure 18:  Global Recombinant Vaccines Market Forecast (US$ Bn), by Others, 2016-2027

Figure 19:  Global Recombinant Vaccines Market Value (US$ Bn), by Region, 2019 & 2027

Figure 20:  North America Recombinant Vaccines Market Value (US$ Bn), by Type, 2019 & 2027

Figure 21:  North America Recombinant Vaccines Market Value Share (%), by Type, 2019

Figure 22:  North America Recombinant Vaccines Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 23:  North America Recombinant Vaccines Market Value Share (%), by Route of Administration, 2019

Figure 24:  North America Recombinant Vaccines Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 25:  North America Recombinant Vaccines Market Value Share (%), by Disease Indication, 2019

Figure 26:  North America Recombinant Vaccines Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 27:  North America Recombinant Vaccines Market Value Share (%), by Distribution Channel, 2019

Figure 28:  North America Recombinant Vaccines Market Value (US$ Bn), By Country, 2019 & 2027

Figure 29:  North America Recombinant Vaccines Market Value Share (%), By Country, 2019

Figure 30:  Europe Recombinant Vaccines Market Value (US$ Bn), by Type, 2019 & 2027

Figure 31:  Europe Recombinant Vaccines Market Value Share (%), by Type, 2019

Figure 32:  Europe Recombinant Vaccines Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 33:  Europe Recombinant Vaccines Market Value Share (%), by Route of Administration, 2019

Figure 34:  Europe Recombinant Vaccines Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 35:  Europe Recombinant Vaccines Market Value Share (%), by Disease Indication, 2019

Figure 36:  Europe Recombinant Vaccines Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 37:  Europe Recombinant Vaccines Market Value Share (%), by Distribution Channel, 2019

Figure 38:  Europe Recombinant Vaccines Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 39:  Europe Recombinant Vaccines Market Value Share (%), By Country/ Sub-region, 2019

Figure 40:  Asia Pacific Recombinant Vaccines Market Value (US$ Bn), by Type, 2019 & 2027

Figure 41:  Asia Pacific Recombinant Vaccines Market Value Share (%), by Type, 2019

Figure 42:  Asia Pacific Recombinant Vaccines Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 43:  Asia Pacific Recombinant Vaccines Market Value Share (%), by Route of Administration, 2019

Figure 44:  Asia Pacific Recombinant Vaccines Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 45:  Asia Pacific Recombinant Vaccines Market Value Share (%), by Disease Indication, 2019

Figure 46:  Asia Pacific Recombinant Vaccines Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 47:  Asia Pacific Recombinant Vaccines Market Value Share (%), by Distribution Channel, 2019

Figure 48:  Asia Pacific Recombinant Vaccines Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 49:  Asia Pacific Recombinant Vaccines Market Value Share (%), By Country/ Sub-region, 2019

Figure 50:  Latin America Recombinant Vaccines Market Value (US$ Bn), by Type, 2019 & 2027

Figure 51:  Latin America Recombinant Vaccines Market Value Share (%), by Type, 2019

Figure 52:  Latin America Recombinant Vaccines Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 53:  Latin America Recombinant Vaccines Market Value Share (%), by Route of Administration, 2019

Figure 54:  Latin America Recombinant Vaccines Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 55:  Latin America Recombinant Vaccines Market Value Share (%), by Disease Indication, 2019

Figure 56:  Latin America Recombinant Vaccines Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 57:  Latin America Recombinant Vaccines Market Value Share (%), by Distribution Channel, 2019

Figure 58:  Latin America Recombinant Vaccines Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 59:  Latin America Recombinant Vaccines Market Value Share (%), By Country/ Sub-region, 2019

Figure 60:  Middle East & Africa Recombinant Vaccines Market Value (US$ Bn), by Type, 2019 & 2027

Figure 61:  Middle East & Africa Recombinant Vaccines Market Value Share (%), by Type, 2019

Figure 62:  Middle East & Africa Recombinant Vaccines Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 63:  Middle East & Africa Recombinant Vaccines Market Value Share (%), by Route of Administration, 2019

Figure 64:  Middle East & Africa Recombinant Vaccines Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 65:  Middle East & Africa Recombinant Vaccines Market Value Share (%), by Disease Indication, 2019

Figure 66:  Middle East & Africa Recombinant Vaccines Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 67:  Middle East & Africa Recombinant Vaccines Market Value Share (%), by Distribution Channel, 2019

Figure 68:  Middle East & Africa Recombinant Vaccines Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 69:  Middle East & Africa Recombinant Vaccines Market Value Share (%), By Country/ Sub-region, 2019

Figure 70:  Global Recombinant Vaccines Market Share (%), By Company, 2019
  • Global
  • 2019
  • 2016-2018
  • 156
  • PRICE
  • $ 4850
    $ 5850
    $ 6850
    Buy Now

Healthcare Clients